Scientific Fraud, Publication Bias, and Honorary Authorship in Nuclear Medicine

J Nucl Med. 2023 Feb;64(2):200-203. doi: 10.2967/jnumed.122.264679. Epub 2022 Sep 8.

Abstract

Our objective was to investigate nuclear medicine scientists' experience with scientific fraud, publication bias, and honorary authorship. Methods: Corresponding authors who published an article in one of the 15 general nuclear medicine journals (according to Journal Citation Reports) in 2021 received an invitation to participate in a survey on scientific integrity. Results: In total, 254 (12.4%) of 1,897 corresponding authors completed the survey, of whom 11 (4.3%) admitted to having committed scientific fraud and 54 (21.3%) reported having witnessed or suspected scientific fraud by someone in their department in the past 5 y. Publication bias was considered present by 222 (87.4%) respondents, and honorary authorship practices were experienced by 100 (39.4%) respondents. Respondents assigned a median score of 8 (range, 2-10) on a 1- to 10-point scale for their overall confidence in the integrity of published work. On multivariate analysis, researchers in Asia had significantly more confidence in the integrity of published work, with a β-coefficient of 0.983 (95% CI, 0.512-1.454; P < 0.001). A subset of 22 respondents raised additional concerns, mainly about authorship criteria and assignments, the generally poor quality of published studies, and perverse incentives of journals and publishers. Conclusion: Scientific fraud, publication bias, and honorary authorship appear to be nonnegligible practices in nuclear medicine. Overall confidence in the integrity of published work is high, particularly among researchers in Asia.

Keywords: fraud; medical imaging; nuclear medicine; research; scientific misconduct.

MeSH terms

  • Authorship
  • Biomedical Research*
  • Editorial Policies
  • Nuclear Medicine*
  • Publication Bias
  • Publishing
  • Scientific Misconduct*